One Neuroscience and Pain Learning Zone
Read time: 15 mins
Last updated:20th Jun 2022
Published:20th Jun 2022
Interview with Dr Wallace Brownlee, Neurologist and Multiple Sclerosis Specialist, Queen's Square MS Centre, London
the implications of COVID-19 for patients on disease-modifying therapies for multiple sclerosis (MS) / key considerations for family planning decisions in patients with MS / safety of MS therapies during pregnancy and breastfeeding
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.